Differential aspects between cobalt-chromium everolimus drug-eluting stent and Absorb everolimus bioresorbable vascular scaffold: from bench to clinical use

被引：9
作者：
Sotomi, Yohei [1 ]
Suwannasom, Pannipa [1 ,2 ,3 ]
Tenekecioglu, Erhan [2 ]
Tateishi, Hiroki [2 ]
Abdelghani, Mohammad [1 ]
Serruys, Patrick W. [4 ]
Onuma, Yoshinobu [2 ]
机构：
[1] Univ Amsterdam, Acad Med Ctr, Amsterdam, Netherlands
[2] Erasmus MC, ThoraxCtr, Rotterdam, Netherlands
[3] Chiang Mai Univ, Fac Med, Northern Region Heart Ctr, Chiang Mai, Thailand
[4] Imperial Coll London, NHLI, Int Ctr Circulatory Hlth, London, England
来源：
EXPERT REVIEW OF CARDIOVASCULAR THERAPY | 2015年 / 13卷 / 10期
关键词：
bioresorbable vascular scaffold; drug-eluting stent; intravascular imaging; percutaneous coronary intervention; randomized controlled trial;
D O I：
10.1586/14779072.2015.1089172
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Drug-eluting stents have significantly improved the outcomes of percutaneous coronary intervention by substantially reducing in-stent restenosis and stent thrombosis. However, a potential limitation of these stents is the permanent presence of a metallic foreign body within the artery, which may cause vascular inflammation, restenosis, thrombosis, neoatherosclerosis, permanent impairment of the physiological vasomotor function and interference with potential future grafting of the stented segment. Bioresorbable scaffolds have the potential to overcome these limitations as they provide temporary scaffolding and then disappear, liberating the treated vessel from its cage and restoring pulsatility, cyclical strain, physiological shear stress and mechanotransduction. This article presents a comparison between the most widespread bioresorbable vascular scaffold 'Absorb BVS' and second-generation drug-eluting stent (cobalt chromium everolimus-eluting stent) from bench to clinical use.
引用
收藏
页码：1127 / 1145
页数：19
相关论文
共 97 条
  • [1] Guiteras-Val P., Varas-Lorenzo C., Garcia-Picart J., Et al., Clinical and sequential angiographic follow-up six months and 10 years after successful percutaneous transluminal coronary angioplasty, The Am J Cardiol, 83, 6, pp. 868-874, (1999)
  • [2] Hatrick R.I., Ormiston J.A., Ruygrok P.N., Et al., Very late changes in the dilated lesion following coronary balloon angioplasty: A 17 year serial quantitative angiographic study, EuroIntervention, 5, 1, pp. 121-126, (2009)
  • [3] Fischman D.L., Leon M.B., Baim D.S., Et al., A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease, N Engl J Med, 331, 8, pp. 496-501, (1994)
  • [4] Serruys P.W., De Jaegere P., Kiemeneij F., Et al., A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease, N Engl J Med, 331, 8, pp. 489-495, (1994)
  • [5] Serruys P.W., Daemen J., Are drug-eluting stents associated with a higher rate of late thrombosis than bare metal stents? Late stent thrombosis: A nuisance in both bare metal and drug-eluting stents, Circulation, 115, 11, pp. 1433-1439, (2007)
  • [6] Ong A.T., McFadden E.P., Regar E., Et al., Late angiographic stent thrombosis (LAST) events with drug-eluting stents, J Am Coll Cardiol, 45, 12, pp. 2088-2092, (2005)
  • [7] McFadden E.P., Stabile E., Regar E., Et al., Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy, Lancet, 364, 9444, pp. 1519-1521, (2004)
  • [8] Camenzind E., Steg P.G., Wijns W., Stent thrombosis late after implantation of first-generation drug-eluting stents: A cause for concern, Circulation, 115, 11, pp. 1440-1455, (2007)
  • [9] Lagerqvist B., James S.K., Stenestrand U., Et al., Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden, N Engl J Med, 356, 10, pp. 1009-1019, (2007)
  • [10] Pfisterer M., Brunner-La Rocca H.P., Buser P.T., Et al., Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: An observational study of drug-eluting versus bare-metal stents, J Am Coll Cardiol, 48, 12, pp. 2584-2591, (2006)
12345678910